Cargando…
Controlled release of nitric oxide for enhanced tumor drug delivery and reduction of thrombosis risk
Platelets activation and hypercoagulation induced by tumor cell-specific thrombotic secretions such as tissue factor (TF) and cancer procoagulant (CP), microparticles (MPs), and cytokines not only increase cancer-associated thrombosis but also accelerate cancer progress. In addition, the tumor heter...
Autores principales: | Liu, Rui, Xu, Baofeng, Ma, Zhifang, Ye, Hongbo, Guan, Xinghua, Ke, Yue, Xiang, Zehong, Shi, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650582/ https://www.ncbi.nlm.nih.gov/pubmed/36425712 http://dx.doi.org/10.1039/d2ra05438h |
Ejemplares similares
-
Bioactive fibrous scaffolds with programmable release of polypeptides regulate inflammation and extracellular matrix remodeling
por: Xiang, Zehong, et al.
Publicado: (2023) -
Stearic acid modified nano CuMOFs used as a nitric oxide carrier for prolonged nitric oxide release
por: Huang, Maotao, et al.
Publicado: (2022) -
Tuning the nitric oxide release from CPO-27 MOFs
por: Cattaneo, Damiano, et al.
Publicado: (2016) -
Nitric Oxide (NO)-Releasing Macromolecules: Rational Design and Biomedical Applications
por: Cheng, Jian, et al.
Publicado: (2019) -
Nitric oxide-releasing emulsion with hyaluronic acid and vitamin E
por: Yapor, Janet P., et al.
Publicado: (2019)